While TB-500 has compelling animal data, theres almost no research performed on the peptide in humans
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
Histological analysis reveals treated wounds exhibit better organized collagen architecture with reduced excessive scarring
Bacteriostatic Water for Aegis Peptides
Many patients seek Wolverine Therapy for: Slow injury recovery or chronic pain Fatigue, low energy, or poor sleep Brain fog or mental sluggishness Reduced workout performance or prolonged soreness Your consultation helps determine whether this therapy aligns with your health needs and goals
While side effects are possible, theyre usually mild and temporary
